Erythropoietin in cardiovascular diseases
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Several studies showed that anaemia is commonly observed in patients with Chronic Heart Failure (CHF) and is associated with worsened symptoms and survival. When anaemia in these patients is treated with erythropoietin (EPO), a significant improvement in cardiac function and symptoms was observed. Although it was originally believed that EPO specifically acted on haematopoietical cells, recent evidence demonstrated several non-haematopoietical effects. Ischaemia/reperfusion experiments in rat heart and brain showed large infarct reduction when treated with EPO. Other effects of EPO are related to its pro-angiogenic effects on endothelial cells, which could be of potential value in patients with ischaemic heart disease. These preclinical findings suggest that EPO may have potential effects in cardiovascular disease beyond correction of haemoglobin levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 1×
“Expression of HIF- 1α increases exponentially, as cellular O2 concentration decreases( 1 ).”
BackgroundBesarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
Apoptosis in the Failing Human Heart
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361603 · Cited by 1,673 · cited 12×
“18,19 Besarab et al. studied 1233 haemodialysis patients with clinically evident ischaemic heart disease or CHF.”
BackgroundInfluentialEzekowitz, J. A., McAlister, F. A., & Armstrong, P. W. (2003) · Circulation · doi:10.1161/01.cir.0000052622.51963.fc · Cited by 866 · cited 2×
“More evidence that anaemia is associated with in impaired survival was provided by Ezekowitz et al. 29 They studied a large communitybased cohort of patients (n=12.065) and found that anaemia is observed in 17% of the patients and an independent prognostic marker for mortality.”
BackgroundInfluentialApoptosis in human acute myocardial infarction.
Saraste, A., Pulkki, K., Kallajoki, M., Henriksen, K., Parvinen, M., & Voipio-Pulkki, L.-M. (1997) · Circulation · doi:10.1161/01.cir.95.2.320 · Cited by 825 · cited 11×
“18,19 Besarab et al. studied 1233 haemodialysis patients with clinically evident ischaemic heart disease or CHF.”
BackgroundInfluentialPlasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
Rauchhaus, M., Doehner, W., Francis, D. P., Davos, C., Kemp, M., Liebenthal, C., Niebauer, J., Hooper, J., Volk, H.-D., Coats, A. J. S., et al. (2000) · Circulation · doi:10.1161/01.cir.102.25.3060 · Cited by 810
Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., & Borenstein, J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01854-5 · Cited by 712 · cited 4×
“1 One-year mortality in NYHA functional class III and IV patients for the different haemoglobin levels.(26) Anemia”
BackgroundMethodInfluential
Cited by
Anemia and Mortality in Heart Failure Patients
Groenveld, H. F., Januzzi, J. L., Damman, K., van Wijngaarden, J., Hillege, H. L., van Veldhuisen, D. J., & van der Meer, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.061 · Cited by 764
van Deursen, V. M., Urso, R., Laroche, C., Damman, K., Dahlström, U., Tavazzi, L., Maggioni, A. P., & Voors, A. A. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.30 · Cited by 468
Self-citationVlagopoulos, P. T., Tighiouart, H., Weiner, D. E., Griffith, J., Pettitt, D., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030226 · Cited by 314
van der Meer, P., Lipsic, E., Henning, R. H., Boddeus, K., van der Velden, J., Voors, A. A., van Veldhuisen, D. J., van Gilst, W. H., & Schoemaker, R. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.044 · Cited by 257
Self-citationPrognostic value of plasma erythropoietin on mortality in patients with chronic heart failure
van der Meer, P., Voors, A. A., Lipsic, E., Smilde, T. D. J., van Gilst, W. H., & van Veldhuisen, D. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.052 · Cited by 190
“Therefore one might assume beneficial effects of EPO treatment in CHF patients( 18 ).”
BackgroundSelf-citation
Metadata
- Authors
- van der Meer, P.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02
- Volume
- 25
- Issue
- 4
- Pages
- 285-291
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2097949483
- Cited by
- 151
- References
- 7
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.